EP0182546A3 - Essai immunologique - Google Patents

Essai immunologique Download PDF

Info

Publication number
EP0182546A3
EP0182546A3 EP85308070A EP85308070A EP0182546A3 EP 0182546 A3 EP0182546 A3 EP 0182546A3 EP 85308070 A EP85308070 A EP 85308070A EP 85308070 A EP85308070 A EP 85308070A EP 0182546 A3 EP0182546 A3 EP 0182546A3
Authority
EP
European Patent Office
Prior art keywords
antibody
immunoassay
modified
reduces
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP85308070A
Other languages
German (de)
English (en)
Other versions
EP0182546A2 (fr
Inventor
John Landon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
POLYCLONAL ANTIBODIES Ltd
Original Assignee
POLYCLONAL ANTIBODIES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by POLYCLONAL ANTIBODIES Ltd filed Critical POLYCLONAL ANTIBODIES Ltd
Publication of EP0182546A2 publication Critical patent/EP0182546A2/fr
Publication of EP0182546A3 publication Critical patent/EP0182546A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
EP85308070A 1984-11-12 1985-11-06 Essai immunologique Withdrawn EP0182546A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848428487A GB8428487D0 (en) 1984-11-12 1984-11-12 Immunoassays
GB8428487 1984-11-12

Publications (2)

Publication Number Publication Date
EP0182546A2 EP0182546A2 (fr) 1986-05-28
EP0182546A3 true EP0182546A3 (fr) 1987-09-09

Family

ID=10569579

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85308070A Withdrawn EP0182546A3 (fr) 1984-11-12 1985-11-06 Essai immunologique

Country Status (2)

Country Link
EP (1) EP0182546A3 (fr)
GB (1) GB8428487D0 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6040137A (en) 1995-04-27 2000-03-21 Tripep Ab Antigen/antibody specification exchanger
SE9401460D0 (sv) * 1994-04-28 1994-04-28 Ferring Ab Antigen/antibody specificity exhanger
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
DE4418513A1 (de) * 1994-05-27 1995-11-30 Bayer Ag Immuntest zum Nachweis hochmolekularer Antigene
JPH11153599A (ja) * 1997-11-21 1999-06-08 Dai Ichi Pure Chem Co Ltd 免疫学的測定方法
JP2000310638A (ja) * 1999-04-28 2000-11-07 Fuji Photo Film Co Ltd 均一系酵素免疫分析方法
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
EP2230249A3 (fr) 2003-02-06 2010-12-22 ChronTech Pharma AB Antigène/anticorps ou ligand/récepteur glycosyles avec un échangeur de spécificité

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298592A (en) * 1979-04-05 1981-11-03 Mallinckrodt, Inc. Double antibody separation method
US4469787A (en) * 1982-05-14 1984-09-04 Mallinckrodt Inc. Immunoassay involving soluble complex of second antibody and labeled binding protein
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
US4522922A (en) * 1982-04-16 1985-06-11 Jose Carro Soluble assay
US4548908A (en) * 1983-05-06 1985-10-22 Sclavo, Inc. Competitive immunofluorescence assay and test kit

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298592A (en) * 1979-04-05 1981-11-03 Mallinckrodt, Inc. Double antibody separation method
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
US4522922A (en) * 1982-04-16 1985-06-11 Jose Carro Soluble assay
US4469787A (en) * 1982-05-14 1984-09-04 Mallinckrodt Inc. Immunoassay involving soluble complex of second antibody and labeled binding protein
US4548908A (en) * 1983-05-06 1985-10-22 Sclavo, Inc. Competitive immunofluorescence assay and test kit

Also Published As

Publication number Publication date
EP0182546A2 (fr) 1986-05-28
GB8428487D0 (en) 1984-12-19

Similar Documents

Publication Publication Date Title
GR850899B (fr)
IL88248A (en) Solid phase immunoassay for detecting hiv antigens using kc-57 monoclonal antibody, and kit for the performance thereof
EP0182546A3 (fr) Essai immunologique
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
EP0249418A3 (fr) Essai immunologique pour dosage d'immunoglobuline avec un procédé de contrôle intégré
ES8802406A1 (es) Un metodo para detectar el anticuerpo para el antigeno superficial de la hepatitis b de subtipona como divisional de la patente de invencion 545.205 del 15-7-85
AU565028B2 (en) Process using monoclonal antibodies for the determination of pancreatic alpha-amylase
EP0368273A3 (fr) Méthode pour essayer un antigène
EP0109012A3 (fr) Dosage de streptococci
EP0158291A3 (fr) Méthode de purification d'antigène carcino-embryonaire et méthode de production d'un anticorps monoclonal reagissant avec l'antigène carcino-embryonaire
AU687932B2 (en) A method for the determinatin of antigens or antibodies in the presence of an immune complex
SE8502722L (sv) Sett att bestemma fc-dels-bindande bakteriella polypeptider
AU556178B1 (en) Process and monoclonal antibodies to assay follicle- stimulating hormone
AU2440188A (en) Immunoassays using antigens produced in heterologous organisms
CA2054689A1 (fr) Une methode d'immunoessai pour determiner la specificite de liaison entre un anticorps monoclonal et un antigene
ES8401261A1 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
KR900002074A (ko) 감마 아트리알 나트륨 이뇨성 폴리펩티드를 인식하는 단일 클론 항체
FI882019A0 (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
EP0173973A3 (fr) Méthode de détermination de l'hormone stimulant la thyroide
EP0174026A3 (en) Nonspecific-reaction inhibitor in an immunological assay with monoclonal antibody
EP0193881A3 (en) Method and reagent for the determination of a luteinizing hormone, as well as the appropriate monoclonal hormone
EP0351244A3 (fr) Anticorps et méthodes d'immunoessais les utilisant
AU6205290A (en) Method for the detection of analytes
EP0322102A3 (fr) Méthodes et essais de capture d'antigènes et composés pour leur mise en oeuvre

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): BE CH DE FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): BE CH DE FR GB IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19880310

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LANDON, JOHN